News | Gerstner Sloan-Kettering Graduate School of Biomedical Sciences

First Four Students Receive Doctoral Degrees from Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences

publicaffairs@mskcc.org (Public Affairs) — Wed, 16 May 2012 18:52:02 +0000

Friday, May 18, 2012

As part of Memorial Sloan-Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.

The New Yorker Features Immune Therapy Work of Memorial Sloan-Kettering Researchers

publicaffairs@mskcc.org (Public Affairs) — Thu, 19 Apr 2012 21:16:03 +0000

Friday, April 20, 2012

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

An Interview with Cancer Biologist Michael Kharas

publicaffairs@mskcc.org (Public Affairs) — Wed, 11 Apr 2012 13:05:41 +0000

Wednesday, April 11, 2012

As a child, Michael Kharas knew that he wanted to “be making the drugs doctors use to cure people.” Today he investigates molecular processes that stem cells and tumor cells have in common – in the hopes of uncovering insights for treatments for cancer and other diseases.

Study Points the Way for Future Therapy to Revive a Damaged Immune System

publicaffairs@mskcc.org (Public Affairs) — Wed, 04 Apr 2012 18:00:18 +0000

Friday, April 6, 2012

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Charles Sawyers Elected President of the American Association for Cancer Research

publicaffairs@mskcc.org (Public Affairs) — Mon, 19 Mar 2012 14:21:16 +0000

Tuesday, March 20, 2012

Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research.

Ping Chi Named to Geoffrey Beene Junior Faculty Chair

publicaffairs@mskcc.org (Public Affairs) — Thu, 01 Mar 2012 18:53:49 +0000

Thursday, March 1, 2012

Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.

Studies Show How Certain Gene Mutations May Promote Cancer

publicaffairs@mskcc.org (Public Affairs) — Wed, 15 Feb 2012 17:20:00 +0000

Wednesday, February 15, 2012

Two Memorial Sloan-Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.

3D Shape of an Ion Channel Revealed

publicaffairs@mskcc.org (Public Affairs) — Wed, 08 Feb 2012 17:44:16 +0000

Wednesday, February 8, 2012

Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.

Cell-Based Therapies Show Promise

publicaffairs@mskcc.org (Public Affairs) — Fri, 09 Dec 2011 17:40:30 +0000

Thursday, December 1, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Genetic Causes of Blood Cancers Explored

publicaffairs@mskcc.org (Public Affairs) — Fri, 09 Dec 2011 16:18:01 +0000

Thursday, December 1, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.